Grants and Contributions:
Agreement Number:
-
Agreement Value:
$658,800.00
Agreement Date:
Apr 1, 2014 - Mar 31, 2019
Description:
Targeting Drug-Insensitive CML Stem Cells with Combination Therapy of New ABL and PP2A Inhibitors
Organization:
Canadian Institutes of Health Research
Location:
Vancouver, British Columbia, CA V6T 1Z1
Reference Number:
236-2013-2014-Q4-00134
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:
Grant or Award spanning more than one fiscal year.
(2014-15 to 2018-19)
Recipient's Legal Name:
JIANG, Xiaoyan
Research Organization:
University of British Columbia